KPMA opposes incentive for low-priced drugs

Published: 2007-10-10 06:59:00

Updated: 2007-10-10 06:59:00

The government's plan to pass a bill aiming at introducing the controversial incentive system for medical institution's low-priced drug purchase in the National Assembly may further promote unfair transactions via behind-the-scene contracts between hospitals and drug makers in the presence of hos...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK